Robeco Institutional Asset Management B.V. Incyte Corp Transaction History

Robeco Institutional Asset Management B.V.

$60.3 Billion
Q2 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Incyte Corp stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 2,386,311 shares of INCY stock, worth $165 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

2,386,311

Previous 1,391,107 71.54%

Holding current value

$165 Million

Previous $84.2 Million 92.93%

% of portfolio

0.27%

Previous 0.17%

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$55.17 - $71.22 $54.9 Million - $70.9 Million	995,204 Added 71.54%	2,386,311 $163 Million
Q1 2025 Apr 23, 2025	BUY	$60.0 - $75.26 $7.82 Million - $9.81 Million	130,320 Added 10.34%	1,391,107 $84.2 Million
Q4 2024 Jan 22, 2025	SELL	$65.08 - $83.38 $337,049 - $431,825	-5,179 Reduced 0.41%	1,260,787 $87.1 Million
Q3 2024 Oct 29, 2024	BUY	$57.33 - $68.61 $4.05 Million - $4.84 Million	70,596 Added 5.91%	1,265,966 $83.7 Million
Q2 2024 Jul 22, 2024	BUY	$51.18 - $63.75 $2.23 Million - $2.78 Million	43,652 Added 3.79%	1,195,370 $72.5 Million
Q1 2024 Apr 24, 2024	BUY	$56.55 - $66.59 $4.86 Million - $5.72 Million	85,941 Added 8.06%	1,151,718 $65.6 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $25 Million - $30.8 Million	479,124 Added 81.67%	1,065,777 $66.9 Million
Q4 2023 Feb 08, 2024	SELL	$52.16 - $64.19 $15 Million - $18.4 Million	-287,287 Reduced 32.87%	586,653 $1.07 Billion
Q3 2023 Oct 23, 2023	BUY	$57.77 - $65.93 $12.2 Million - $13.9 Million	210,820 Added 31.79%	873,940 $50.5 Million
Q2 2023 Jul 24, 2023	BUY	$60.95 - $75.51 $5.25 Million - $6.5 Million	86,116 Added 14.92%	663,120 $41.3 Million
Q1 2023 May 03, 2023	BUY	$70.23 - $86.01 $16.5 Million - $20.2 Million	234,913 Added 68.67%	577,004 $41.7 Million
Q4 2022 Feb 06, 2023	BUY	$67.18 - $84.11 $1.49 Million - $1.87 Million	22,241 Added 6.95%	342,091 $27.5 Million
Q3 2022 Dec 01, 2022	BUY	$66.18 - $82.86 $18.1 Million - $22.6 Million	273,113 Added 584.36%	319,850 $21.3 Million
Q3 2022 Oct 26, 2022	BUY	$66.18 - $82.86 $18.1 Million - $22.6 Million	273,113 Added 584.36%	319,850 $21.3 Million
Q2 2022 Dec 01, 2022	BUY	$66.18 - $83.18 $943,991 - $1.19 Million	14,264 Added 43.93%	46,737 $3.55 Million
Q2 2022 Jul 27, 2022	BUY	$66.18 - $83.18 $943,991 - $1.19 Million	14,264 Added 43.93%	46,737 $3.55 Million
Q1 2022 Dec 01, 2022	BUY	$66.02 - $79.71 $2,640 - $3,188	40 Added 0.12%	32,473 $2.58 Million
Q1 2022 Apr 26, 2022	BUY	$66.02 - $79.71 $2,640 - $3,188	40 Added 0.12%	32,473 $2.58 Million
Q4 2021 Dec 01, 2022	BUY	$63.34 - $74.11 $99,380 - $116,278	1,569 Added 5.08%	32,433 $2.38 Million
Q4 2021 Jan 31, 2022	BUY	$63.34 - $74.11 $99,380 - $116,278	1,569 Added 5.08%	32,433 $2.38 Million
Q3 2021 Dec 01, 2022	SELL	$68.67 - $84.02 $156,773 - $191,817	-2,283 Reduced 6.89%	30,864 $2.12 Million
Q3 2021 Oct 20, 2021	SELL	$68.67 - $84.02 $156,773 - $191,817	-2,283 Reduced 6.89%	30,864 $2.12 Million
Q2 2021 Dec 01, 2022	SELL	$79.87 - $87.53 $7.39 Million - $8.1 Million	-92,550 Reduced 73.63%	33,147 $2.79 Million
Q2 2021 Jul 28, 2021	SELL	$79.87 - $87.53 $7.39 Million - $8.1 Million	-92,550 Reduced 73.63%	33,147 $2.79 Million
Q1 2021 Dec 01, 2022	SELL	$76.02 - $100.5 $14.8 Million - $19.5 Million	-194,153 Reduced 60.7%	125,697 $10.2 Million
Q1 2021 Apr 23, 2021	SELL	$76.02 - $100.5 $7.23 Million - $9.55 Million	-95,072 Reduced 43.06%	125,697 $10.2 Million
Q4 2020 Dec 01, 2022	SELL	$80.74 - $97.7 $8 Million - $9.68 Million	-99,081 Reduced 30.98%	220,769 $19.2 Million
Q4 2020 Jan 28, 2021	SELL	$80.74 - $97.7 $2.94 Million - $3.56 Million	-36,391 Reduced 14.15%	220,769 $19.2 Million
Q3 2020 Oct 29, 2020	BUY	$85.07 - $109.69 $40,493 - $52,212	476 Added 0.19%	257,160 $23.1 Million
Q2 2020 Jul 20, 2020	BUY	$74.18 - $108.93 $1.96 Million - $2.88 Million	26,406 Added 11.47%	256,684 $26.7 Million
Q1 2020 Apr 30, 2020	BUY	$63.18 - $85.97 $2.32 Million - $3.16 Million	36,777 Added 19.01%	230,278 $16.9 Million
Q4 2019 Feb 06, 2020	BUY	$73.04 - $95.72 $6.49 Million - $8.5 Million	88,809 Added 84.83%	193,501 $16.9 Million
Q3 2019 Oct 17, 2019	BUY	$72.82 - $86.52 $4.26 Million - $5.06 Million	58,448 Added 126.39%	104,692 $7.77 Million
Q2 2019 Jul 19, 2019	BUY	$73.52 - $88.7 $3.13 Million - $3.78 Million	42,610 Added 1172.54%	46,244 $3.93 Million
Q2 2018 Aug 03, 2018	SELL	$60.85 - $83.98 $212,975 - $293,930	-3,500 Reduced 49.06%	3,634 $244,000
Q4 2017 Jan 25, 2018	BUY	$93.56 - $116.6 $284,328 - $354,347	3,039 Added 74.21%	7,134 $675,000
Q3 2017 Oct 17, 2017	SELL	$109.15 - $138.27 $292,303 - $370,287	-2,678 Reduced 39.54%	4,095 $478,000
Q2 2017 Aug 08, 2017	SELL	N/A	-426 Reduced 5.92%	6,773 $854,000
Q1 2017 Jan 19, 2021	BUY	N/A	7,199	7,199 $962,000

Others Institutions Holding INCY

# of Institutions

700

Shares Held

195M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Incyte Corp Transaction History